As we approach the close of National Alzheimer's Disease Awareness Month, I've discussed the history of the disease and its impact on a patient's loved ones, but I haven't talked about the extensive, and often silent, effects of Alzheimer's. The burden to people with this chronic illness, to caregivers and to our society rises each year. For these reasons, I'd like to explore the true costs of Alzheimer's disease.
When it comes to new digital trends, you'll rarely hear Congress called an "early adopter." Despite their sluggish reputation, they've grown a lot when it comes to social media usage. Just ask the Congressional Management Foundation (CMF). Last week, CMF's CEO Brad Fitch joined us for a discussion of their #SocialCongress survey. The report explores the ways members of Congress, and their staff, use these tools to communicate and listen to their constituents. What could these findings mean for the future of digital advocacy?
Every five years, Congress revises the Prescription Drug User Fee Act (PDUFA) to modernize the development, review and delivery of new medicines in the United States. PDUFA provides the FDA with the financial and human resources it needs to more efficiently assess applications for new medicines. Each version of the law builds upon an already-solid foundation, continuing a trend of constant improvement to an essential facet of public policy. As we approach the sixth reauthorization of PDUFA, I think it's a good time to examine the numbers behind this law.